
Show Notes
Standard Bots CEO Evan Beard explains why industrial robots are finally starting to move beyond brittle point-by-point programming. Instead of teaching a robot one exact path, teams can increasingly describe a task, demonstrate it through teleoperation or guided motion, and let the system learn how to handle variation in the real world.
The conversation covers natural-language robot programming, learning by demonstration, ugly factory edge cases, the reliability bar for production, and why the most important robotics progress may look less like a humanoid stunt and more like a machine that can handle a shifted part without calling an engineer.
Relevant Article Links: https://standardbots.com/
Subscribe to The Neuron newsletter: https://theneuron.ai
Sponsored by Outshift by Cisco. Learn more: https://outshift.com
Sponsored by Origin. Learn more: https://originhq.com/AIexplained
More from The Neuron: AI Explained
Neurosurgeon-scientists Alex Ksendzovsky and Jon Pomeraniec explain how The Biological Computing Company uses living neurons as a research platform for AI. Their team grows roughly 150,000 cells on a 4,096-electrode array, sends in patterns such as handwritten digits, records how the neurons respond, and models useful computational behaviors in software. They say those neuron-inspired techniques are already helping GPU-based video-generation systems run about 5x faster with roughly 80% lower inference cost, while their longer-term work explores robots, world models, and real-time biological compute.
OpenAI just dropped 20+ announcements at DevDay 2026, so... yeah, we have some things to talk about. 😺
Runway co-founder Anastasis Germanidis explains Solaris, an “interface world model” that generates software frame by frame instead of rendering a traditional interface from HTML and CSS.
OpenAI DevDay 2026 is here, and we’re hosting a watch party to watch the keynote LIVE.
Corey and Grant sit down with Mammoth Biosciences co-founder and CEO Dr. Trevor Martin to explain how CRISPR is moving from a laboratory tool toward one-time medicines.